论文信息 - Association of Patient Sex With Chemotherapy-Related Toxic Effects: A Retrospective Analysis of the PETACC-3 Trial Conducted by the EORTC Gastrointestinal Group

Association of Patient Sex With Chemotherapy-Related Toxic Effects: A Retrospective Analysis of the PETACC-3 Trial Conducted by the EORTC Gastrointestinal Group

Author Affiliations: Department of Radiation Oncology, Dana-Farber/Brigham and Women’s Cancer Center, Harvard Medical School, Boston, Massachusetts (Cagney, Martin, Alexander, Aizer); Department of Biostatistics, Harvard T.H. Chan School of Public Health, Boston, Massachusetts (Catalano); Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Boston, Massachusetts (Catalano); Department of Radiation Oncology, Mayo Clinic, Rochester, Minnesota (Brown); Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts (Lin).

[1] Jun Li,et al. Comprehensive Characterization of Molecular Differences in Cancer between Male and Female Patients. , 2016, Cancer cell.

[2] Y. Ando,et al. An internally and externally validated nomogram for predicting the risk of irinotecan-induced severe neutropenia in advanced colorectal cancer patients , 2015, British Journal of Cancer.

[3] R. Greenblatt,et al. Sex differences in pharmacokinetics and pharmacodynamics. , 2004, Annual review of pharmacology and toxicology.

[4] J. Schellens,et al. Part 1: background, methodology, and clinical adoption of pharmacogenetics. , 2011, The oncologist.

[5] R. Greil,et al. Randomized phase III trial comparing biweekly infusional fluorouracil/leucovorin alone or with irinotecan in the adjuvant treatment of stage III colon cancer: PETACC-3. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[6] R. Bender,et al. Distribution of the UGT1A1*28 polymorphism in Caucasian and Asian populations in the US: a genomic analysis of 138 healthy individuals , 2007, Anti-cancer drugs.